Rondoraptivon pegol

N/A

Report date: 2025/04/11 11:34:19
NME

Base Information

Drug NameRondoraptivon pegol
Drug Alias NameBT-200RBD-2018SR-060
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVon willebrand factor inhibitors
TargetsVon willebrand factor
Therapy Area/IndicationsArterial ThromboembolismHemorrhagic Disordersvon Willebrand Disease, Type 2 +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesBand Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of ViennaSuzhou Ribo Life Science Co Ltd
Inactive CompaniesBand Therapeutics Llc
Active IndicationsArterial ThromboembolismHemorrhagic Disordersvon Willebrand Disease, Type 2 +[5] 
Inactive IndicationsCoronary Artery DiseaseStrokeIntracranial Arteriosclerosis

Other Information

ATC CodeN/A
Related LinksN/A